The sequence of chemotherapy and anti-PD-1 antibody influence the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell cancer: A phase II study.Lingdi Zhao, Quanli Gao, Wenqun Xing et al.|Journal of Clinical Oncology|2021Cited by 15
High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center StudyLingdi Zhao, Quanli Gao, Tiepeng Li et al.|Frontiers in Immunology|2022Cited by 15
Figure S4 from T Cells Expanded from PD-1<sup>+</sup> Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating LymphocytesTiepeng Li, Quanli Gao, Lingdi Zhao et al.|Unknown|2023Cited by 0
Figure S1 from T Cells Expanded from PD-1<sup>+</sup> Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating LymphocytesTiepeng Li, Quanli Gao, Lingdi Zhao et al.|Unknown|2023Cited by 0
Figure S4 from T Cells Expanded from PD-1<sup>+</sup> Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating LymphocytesTiepeng Li, Quanli Gao, Lingdi Zhao et al.|Unknown|2023Cited by 0